US Stock MarketDetailed Quotes

Sangamo Therapeutics (SGMO)

Watchlist
  • 0.4300
  • -0.0030-0.69%
Close Jan 15 16:00 ET
  • 0.4321
  • +0.0021+0.49%
Post 20:01 ET
144.69MMarket Cap-0.96P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Sangamo Therapeutics (SGMO) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Total revenue
-98.82%581K
5,042.13%18.31M
1,238.25%6.44M
-67.20%57.8M
269.78%7.55M
425.77%49.41M
-94.79%356K
-99.70%481K
58.34%176.23M
-92.50%2.04M
Operating revenue
-98.82%581K
5,042.13%18.31M
1,238.25%6.44M
-67.20%57.8M
269.78%7.55M
425.77%49.41M
-94.79%356K
-99.70%481K
58.34%176.23M
-92.50%2.04M
Cost of revenue
Gross profit
Operating expense
-6.83%36.13M
-0.30%36.16M
-24.33%36.07M
-47.07%156.25M
-47.43%33.54M
-45.38%38.78M
-54.13%36.27M
-41.42%47.66M
-5.55%295.22M
-22.77%63.81M
Selling and administrative expenses
-27.67%7.99M
-24.64%9.08M
-14.52%10.06M
-26.88%44.73M
-24.68%9.87M
-20.61%11.05M
-24.78%12.05M
-35.12%11.77M
-2.42%61.17M
-20.34%13.1M
-General and administrative expense
-27.67%7.99M
-24.64%9.08M
-14.52%10.06M
-26.88%44.73M
-24.68%9.87M
-20.61%11.05M
-24.78%12.05M
-35.12%11.77M
-2.42%61.17M
-20.34%13.1M
Research and development costs
1.48%28.14M
11.81%27.08M
-27.54%26.01M
-52.35%111.52M
-53.31%23.68M
-51.42%27.73M
-61.58%24.22M
-43.22%35.89M
-6.34%234.06M
-23.38%50.71M
Operating profit
-434.43%-35.55M
50.28%-17.86M
37.20%-29.63M
17.27%-98.45M
57.92%-25.99M
117.26%10.63M
50.28%-35.91M
-161.58%-47.18M
40.88%-118.99M
-11.50%-61.76M
Net non-operating interest income expense
1.43%355K
-7.21%386K
-31.49%309K
-47.21%5.86M
211.26%4.64M
-90.04%350K
-85.15%416K
-86.30%451K
17.71%11.1M
-59.43%1.49M
Non-operating interest income
1.43%355K
-7.21%386K
-31.49%309K
-47.21%5.86M
211.26%4.64M
-90.04%350K
--416K
--451K
17.71%11.1M
-59.43%1.49M
Total other finance cost
----
----
----
----
----
----
63.24%-1.03M
23.02%-2.54M
----
----
Other net income (expense)
148.42%107K
-346.24%-2.49M
48.83%-1.16M
96.44%-5.52M
-736.82%-2.48M
99.51%-221K
98.91%-558K
96.13%-2.27M
-155.01M
-296K
Special income (charges)
--0
--0
--0
96.44%-5.52M
--0
--0
97.72%-1.17M
92.57%-4.35M
---155.01M
---296K
-Less:Impairment of capital assets
--0
--0
--0
-96.44%5.52M
--0
--0
-97.72%1.17M
-92.57%4.35M
--155.01M
--296K
Other non- operating income (expenses)
148.42%107K
-505.54%-2.49M
-155.61%-1.16M
----
----
---221K
--614K
--2.08M
----
----
Income before tax
-426.12%-35.09M
44.64%-19.96M
37.79%-30.48M
62.68%-98.11M
60.67%-23.82M
110.46%10.76M
70.15%-36.05M
-329.71%-48.99M
-37.04%-262.9M
-17.12%-60.57M
Income tax
-282.95%-161K
-63.51%27K
21.43%119K
96.71%-167K
-56.99%-427K
-93.07%88K
101.18%74K
-49.48%98K
-1,282.28%-5.07M
-205.02%-272K
Net income
-427.31%-34.93M
44.68%-19.99M
37.67%-30.6M
62.01%-97.94M
61.20%-23.4M
110.25%10.67M
68.45%-36.13M
-332.29%-49.09M
-34.09%-257.83M
-16.01%-60.3M
Net income continuous Operations
-427.31%-34.93M
44.68%-19.99M
37.67%-30.6M
62.01%-97.94M
61.20%-23.4M
110.25%10.67M
68.45%-36.13M
-332.29%-49.09M
-34.09%-257.83M
-16.01%-60.3M
Minority interest income
Net income attributable to the parent company
-427.31%-34.93M
44.68%-19.99M
37.67%-30.6M
62.01%-97.94M
61.20%-23.4M
110.25%10.67M
68.45%-36.13M
-332.29%-49.09M
-34.09%-257.83M
-16.01%-60.3M
Preferred stock dividends
Other preferred stock dividends
0
1.29M
Net income attributable to common stockholders
-472.19%-34.93M
44.68%-19.99M
37.67%-30.6M
62.01%-97.94M
61.20%-23.4M
109.01%9.39M
68.45%-36.13M
-332.29%-49.09M
-34.09%-257.83M
-16.01%-60.3M
Basic earnings per share
-320.00%-0.11
55.56%-0.08
48.15%-0.14
66.89%-0.49
67.65%-0.11
108.47%0.05
72.73%-0.18
-307.69%-0.27
-18.40%-1.48
-6.25%-0.34
Diluted earnings per share
-375.00%-0.11
55.56%-0.08
48.15%-0.14
66.89%-0.49
67.65%-0.11
106.78%0.04
72.73%-0.18
-325.00%-0.27
-18.40%-1.48
-6.25%-0.34
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
--
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Total revenue -98.82%581K5,042.13%18.31M1,238.25%6.44M-67.20%57.8M269.78%7.55M425.77%49.41M-94.79%356K-99.70%481K58.34%176.23M-92.50%2.04M
Operating revenue -98.82%581K5,042.13%18.31M1,238.25%6.44M-67.20%57.8M269.78%7.55M425.77%49.41M-94.79%356K-99.70%481K58.34%176.23M-92.50%2.04M
Cost of revenue
Gross profit
Operating expense -6.83%36.13M-0.30%36.16M-24.33%36.07M-47.07%156.25M-47.43%33.54M-45.38%38.78M-54.13%36.27M-41.42%47.66M-5.55%295.22M-22.77%63.81M
Selling and administrative expenses -27.67%7.99M-24.64%9.08M-14.52%10.06M-26.88%44.73M-24.68%9.87M-20.61%11.05M-24.78%12.05M-35.12%11.77M-2.42%61.17M-20.34%13.1M
-General and administrative expense -27.67%7.99M-24.64%9.08M-14.52%10.06M-26.88%44.73M-24.68%9.87M-20.61%11.05M-24.78%12.05M-35.12%11.77M-2.42%61.17M-20.34%13.1M
Research and development costs 1.48%28.14M11.81%27.08M-27.54%26.01M-52.35%111.52M-53.31%23.68M-51.42%27.73M-61.58%24.22M-43.22%35.89M-6.34%234.06M-23.38%50.71M
Operating profit -434.43%-35.55M50.28%-17.86M37.20%-29.63M17.27%-98.45M57.92%-25.99M117.26%10.63M50.28%-35.91M-161.58%-47.18M40.88%-118.99M-11.50%-61.76M
Net non-operating interest income expense 1.43%355K-7.21%386K-31.49%309K-47.21%5.86M211.26%4.64M-90.04%350K-85.15%416K-86.30%451K17.71%11.1M-59.43%1.49M
Non-operating interest income 1.43%355K-7.21%386K-31.49%309K-47.21%5.86M211.26%4.64M-90.04%350K--416K--451K17.71%11.1M-59.43%1.49M
Total other finance cost ------------------------63.24%-1.03M23.02%-2.54M--------
Other net income (expense) 148.42%107K-346.24%-2.49M48.83%-1.16M96.44%-5.52M-736.82%-2.48M99.51%-221K98.91%-558K96.13%-2.27M-155.01M-296K
Special income (charges) --0--0--096.44%-5.52M--0--097.72%-1.17M92.57%-4.35M---155.01M---296K
-Less:Impairment of capital assets --0--0--0-96.44%5.52M--0--0-97.72%1.17M-92.57%4.35M--155.01M--296K
Other non- operating income (expenses) 148.42%107K-505.54%-2.49M-155.61%-1.16M-----------221K--614K--2.08M--------
Income before tax -426.12%-35.09M44.64%-19.96M37.79%-30.48M62.68%-98.11M60.67%-23.82M110.46%10.76M70.15%-36.05M-329.71%-48.99M-37.04%-262.9M-17.12%-60.57M
Income tax -282.95%-161K-63.51%27K21.43%119K96.71%-167K-56.99%-427K-93.07%88K101.18%74K-49.48%98K-1,282.28%-5.07M-205.02%-272K
Net income -427.31%-34.93M44.68%-19.99M37.67%-30.6M62.01%-97.94M61.20%-23.4M110.25%10.67M68.45%-36.13M-332.29%-49.09M-34.09%-257.83M-16.01%-60.3M
Net income continuous Operations -427.31%-34.93M44.68%-19.99M37.67%-30.6M62.01%-97.94M61.20%-23.4M110.25%10.67M68.45%-36.13M-332.29%-49.09M-34.09%-257.83M-16.01%-60.3M
Minority interest income
Net income attributable to the parent company -427.31%-34.93M44.68%-19.99M37.67%-30.6M62.01%-97.94M61.20%-23.4M110.25%10.67M68.45%-36.13M-332.29%-49.09M-34.09%-257.83M-16.01%-60.3M
Preferred stock dividends
Other preferred stock dividends 01.29M
Net income attributable to common stockholders -472.19%-34.93M44.68%-19.99M37.67%-30.6M62.01%-97.94M61.20%-23.4M109.01%9.39M68.45%-36.13M-332.29%-49.09M-34.09%-257.83M-16.01%-60.3M
Basic earnings per share -320.00%-0.1155.56%-0.0848.15%-0.1466.89%-0.4967.65%-0.11108.47%0.0572.73%-0.18-307.69%-0.27-18.40%-1.48-6.25%-0.34
Diluted earnings per share -375.00%-0.1155.56%-0.0848.15%-0.1466.89%-0.4967.65%-0.11106.78%0.0472.73%-0.18-325.00%-0.27-18.40%-1.48-6.25%-0.34
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes------------
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +6.63%
Sample Name
Sample Code
 +3.27%
Sample Name
Sample Code
 +2.15%
4
NVIDIA
NVDA
+2.13%
5
Broadcom
AVGO
+0.92%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +15.64%
Sample Name
Sample Code
 +12.57%
Sample Name
Sample Code
 +10.73%
4
Alibaba
BABA
+10.66%
5
Taiwan Semiconductor
TSM
+7.43%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -